Skip to main content
ClinicalTrials.govcontrolled

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

ClinicalTrials.gov study NCT03340766. IPD Sharing: YES. Countries: 6. Publications: 0.

ShareScore

28/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship
12
Harmonization
8
Access
4
Reuse readiness
0
Engagement
4

Topics